| HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
| CYP21A2 |
P08686
|
cytochrome P450 family 21 subfamily A member 2
|
|
2.6E-04 |
0.525 |
0.769 |
| HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
| ZFHX3 |
Q15911 Q6ZP98
|
zinc finger homeobox 3
|
|
0.45 |
0.621 |
0.654 |
| MAPT |
P10636
|
microtubule associated protein tau
|
|
6.0E-03 |
0.446 |
0.923 |
| RERE |
Q9P2R6
|
arginine-glutamic acid dipeptide repeats
|
|
1.00 |
0.526 |
0.846 |
| CSMD1 |
Q96PZ7
|
CUB and Sushi multiple domains 1
|
|
1.00 |
0.610 |
0.500 |
| PSORS1C1 |
Q9UIG5
|
psoriasis susceptibility 1 candidate 1
|
|
2.7E-04 |
0.656 |
0.731 |
| ASTN2 |
O75129
|
astrotactin 2
|
|
1.00 |
0.666 |
0.462 |
| KANSL1 |
Q7Z3B3
|
KAT8 regulatory NSL complex subunit 1
|
|
1.00 |
0.592 |
0.731 |
| SOX6 |
P35712
|
SRY-box transcription factor 6
|
|
1.00 |
0.578 |
0.615 |
| MAD1L1 |
Q9Y6D9
|
mitotic arrest deficient 1 like 1
|
|
6.8E-16 |
0.570 |
0.731 |
| FHIT |
P49789
|
fragile histidine triad diadenosine triphosphatase
|
|
5.7E-03 |
0.444 |
0.846 |
| CRB1 |
P82279
|
crumbs cell polarity complex component 1
|
|
5.6E-16 |
0.570 |
0.654 |
| LINC01122 |
|
long intergenic non-protein coding RNA 1122
|
|
|
0.821 |
0.269 |
| MAPT-AS1 |
|
MAPT antisense RNA 1
|
|
|
0.711 |
0.269 |
| ANK3 |
Q12955
|
ankyrin 3
|
|
1.00 |
0.578 |
0.654 |
| FAM13A |
O94988
|
family with sequence similarity 13 member A
|
|
1.9E-18 |
0.653 |
0.462 |
| LINC02210-CRHR1 |
P34998
|
LINC02210-CRHR1 readthrough
|
|
|
0.570 |
0.692 |
| AUTS2 |
Q8WXX7
|
activator of transcription and developmental regulator AUTS2
|
|
1.00 |
0.569 |
0.846 |
| DELEC1 |
Q9P2X7
|
deleted in esophageal cancer 1
|
|
2.7E-05 |
0.573 |
0.692 |
| ZBTB20 |
Q9HC78
|
zinc finger and BTB domain containing 20
|
|
0.97 |
0.566 |
0.731 |
| CNNM2 |
Q9H8M5
|
cyclin and CBS domain divalent metal cation transport mediator 2
|
|
1.00 |
0.641 |
0.346 |
| LINC00461 |
|
long intergenic non-protein coding RNA 461
|
|
|
0.736 |
0.423 |
| BORCS7-ASMT |
|
BORCS7-ASMT readthrough (NMD candidate)
|
|
|
0.805 |
0.154 |